Aytu BioPharma, Inc. (NASDAQ:AYTU) Short Interest Up 8.3% in January

Aytu BioPharma, Inc. (NASDAQ:AYTU) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 137,300 shares, an increase of 8.3% from the December 31st total of 126,800 shares. Based on an average daily volume of 33,600 shares, the days-to-cover ratio is currently 4.1 days. Approximately 2.3% of the shares of the company are short sold.

Aytu BioPharma Stock Down 1.5 %

Shares of AYTU opened at $1.64 on Tuesday. The company has a current ratio of 0.99, a quick ratio of 0.80 and a debt-to-equity ratio of 0.35. The firm has a market cap of $10.09 million, a P/E ratio of -1.33 and a beta of -1.45. The stock’s 50 day moving average is $1.62 and its two-hundred day moving average is $2.07. Aytu BioPharma has a 12 month low of $1.30 and a 12 month high of $3.45.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Aytu BioPharma stock. Dimensional Fund Advisors LP boosted its stake in Aytu BioPharma, Inc. (NASDAQ:AYTU) by 54.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 23,551 shares of the company’s stock after purchasing an additional 8,311 shares during the period. Dimensional Fund Advisors LP owned about 0.39% of Aytu BioPharma worth $69,000 at the end of the most recent quarter. Institutional investors and hedge funds own 33.49% of the company’s stock.

About Aytu BioPharma

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.